GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Epigral Ltd (NSE:EPIGRAL) » Definitions » Total Assets
中文

Epigral (NSE:EPIGRAL) Total Assets

: ₹27,943 Mil (As of Mar. 2024)
View and export this data going back to 2021. Start your Free Trial

Epigral's Total Assets for the quarter that ended in Mar. 2024 was ₹27,943 Mil.

During the past 12 months, Epigral's average Total Assets Growth Rate was 14.50% per year. During the past 3 years, the average Total Assets Growth Rate was 23.80% per year. During the past 5 years, the average Total Assets Growth Rate was 24.90% per year.

During the past 7 years, Epigral's highest 3-Year average Total Assets Growth Rate was 34.60%. The lowest was 23.50%. And the median was 27.85%.

Total Assets is connected with ROA %. Epigral's annualized ROA % for the quarter that ended in Mar. 2024 was 11.05%. Total Assets is also linked to Revenue through Asset Turnover. Epigral's Asset Turnover for the quarter that ended in Mar. 2024 was 0.19.


Epigral Total Assets Historical Data

The historical data trend for Epigral's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epigral Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Assets
Get a 7-Day Free Trial 12,734.62 14,487.02 21,236.66 24,322.35 27,943.42

Epigral Quarterly Data
Mar18 Mar19 Mar20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24,322.35 - 26,482.14 - 27,943.42

Epigral Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Epigral's Total Assets for the fiscal year that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (A: Mar. 2024 )+Total Liabilities (A: Mar. 2024 )
=12541.007+15402.409
=27,943

Epigral's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=12541.007+15402.409
=27,943

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Epigral  (NSE:EPIGRAL) Total Assets Explanation

Total Assets is connected with ROA %.

Epigral's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=3089.144/( (0+27943.416)/ 1 )
=3089.144/27943.416
=11.05 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Epigral's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=5246.33/( (0+27943.416)/ 1 )
=5246.33/27943.416
=0.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Epigral Total Assets Related Terms

Thank you for viewing the detailed overview of Epigral's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Epigral (NSE:EPIGRAL) Business Description

Traded in Other Exchanges
Address
Corporate Road, 5th Floor, 6th Floor & 7th Floor, Meghmani House, Behind Safal Profitaire, Prahladnagar, Ahmedabad, GJ, IND, 380015
Epigral Ltd Formerly Meghmani Finechem Ltd is a producer of Chlor-Alkali and its Derivatives and specialty chemicals with backward and forward integration facilities. It manufactures Caustic Soda, Caustic Potash, CPVC Resin, Epichlorohydrin, Chlorine, Hydrogen, Chloromethanes, and Hydrogen Peroxide. The company is focused on servicing domestic as well as international markets.

Epigral (NSE:EPIGRAL) Headlines

No Headlines